Latest Dilution News

Pursuit Minerals has issued over 8.5 million placement options and additional shares to directors following shareholder approval, setting the stage for potential capital inflows through option exercises by mid-2027.

Peak Rare Earths Limited has updated its acquisition scheme, replacing Ganzhou Chenguang with Shenghe Resources (Singapore) Pte. Ltd. as the acquiring party, simplifying regulatory hurdles and valuing the company at nearly A$158 million.

Collins Foods Limited has updated its dividend announcement, confirming a fully franked ordinary dividend of AUD 0.15 per share and revealing the Dividend Reinvestment Plan price at AUD 8.92 per share.

Zelira Therapeutics has locked in a $650,000 loan facility secured against its anticipated FY25 R&D tax rebate, aiming to accelerate its HOPE SPV clinical trial and strengthen working capital.

Capricorn Metals has announced a definitive plan to acquire Warriedar Resources, consolidating key Western Australian gold assets and enhancing production capacity. The all-scrip deal offers Warriedar shareholders a 29% premium and positions Capricorn for a combined 9.1 million ounce gold equivalent resource.

Sun Silver Limited has raised $30 million through a major institutional placement to accelerate drilling and development at its flagship Maverick Springs Silver-Gold Project in Nevada.

NOVONIX has entered a multi-tranche funding agreement with Yorkville Advisors to raise up to US$100 million through convertible debentures, supporting its Riverside facility build-out and commercial production ramp-up.

Red Mountain Mining has partnered with Canadian exploration experts Fladgate to advance its Fry Lake Gold Project, while seeking Ontario government funding to offset exploration costs.

Australian Strategic Materials has successfully closed an oversubscribed Share Purchase Plan, raising nearly A$12 million at a 20% discount to recent market prices.

Patrys Limited has announced a fully underwritten entitlement offer to raise approximately $1.77 million, aimed at funding ongoing research and development of its PAT-DX3 therapy and supporting working capital. The offer includes secondary options and shares, subject to shareholder approval, and will significantly expand the company's capital base.

Mantle Minerals has received conversion notices for over half of its outstanding convertible notes, prompting a shareholder vote in September to decide on converting $742,000 of debt into shares with attached options.

Patrys Limited has launched a fully underwritten entitlement offer to raise approximately $1.77 million, aiming to accelerate development and commercial activities around its deoxymabs program.